Yuyao Biotechnology Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Yuyao Biotechnology General Information
Description
Developer of new drugs designed for tumors, neurodegenerative diseases, and autoimmune diseases. The company's technology utilizes artificial intelligence and a G protein-coupled receptor platform to develop small-molecule antagonists and inhibitors, providing healthcare providers with therapeutic options for advanced solid tumors and hematological malignancies.
Contact Information
Website
www.yuyaobiotech.comCorporate Office
- 10th Floor, Building A
- Number 58 Tanzhu Road, Minhang District
- Shanghai, 201109
- China
Corporate Office
- 10th Floor, Building A
- Number 58 Tanzhu Road, Minhang District
- Shanghai, 201109
- China
Yuyao Biotechnology Timeline
Yuyao Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 20-Oct-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 29-Apr-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 03-Jan-2023 | $12.9M | $19.1M | Completed | Generating Revenue | |
| 1. Early Stage VC | 28-Jun-2021 | $6.23M | $6.23M | Completed | Generating Revenue |
Yuyao Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Yuyao Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Yuyao Biotechnology Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hunan Xiangjiang Xincheng Private Equity Fund Management | Venture Capital | Minority | ||
| Qiming Venture Partners | Venture Capital | Minority | ||
| Shanghai Highpower Industrial | Corporation | Minority | ||
| HuaE Finance Management | Venture Capital | Minority | ||
| Huzhou Yongshi Equity Investment Management | Growth/Expansion | Minority |
Yuyao Biotechnology FAQs
-
When was Yuyao Biotechnology founded?
Yuyao Biotechnology was founded in 2020.
-
Where is Yuyao Biotechnology headquartered?
Yuyao Biotechnology is headquartered in Shanghai, China.
-
What is the size of Yuyao Biotechnology?
Yuyao Biotechnology has 50 total employees.
-
What industry is Yuyao Biotechnology in?
Yuyao Biotechnology’s primary industry is Drug Discovery.
-
Is Yuyao Biotechnology a private or public company?
Yuyao Biotechnology is a Private company.
-
What is Yuyao Biotechnology’s current revenue?
The current revenue for Yuyao Biotechnology is .
-
How much funding has Yuyao Biotechnology raised over time?
Yuyao Biotechnology has raised $90.3M.
-
Who are Yuyao Biotechnology’s investors?
Hunan Xiangjiang Xincheng Private Equity Fund Management, Qiming Venture Partners, Shanghai Highpower Industrial, HuaE Finance Management, and Huzhou Yongshi Equity Investment Management are 5 of 6 investors who have invested in Yuyao Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
